Cargando…
Percepta Genomic Sequencing Classifier and decision-making in patients with high-risk lung nodules: a decision impact study
BACKGROUND: Incidental and screening-identified lung nodules are common, and a bronchoscopic evaluation is frequently nondiagnostic. The Percepta Genomic Sequencing Classifier (GSC) is a genomic classifier developed in current and former smokers which can be used for further risk stratification in t...
Autores principales: | Sethi, Sonali, Oh, Scott, Chen, Alexander, Bellinger, Christina, Lofaro, Lori, Johnson, Marla, Huang, Jing, Bhorade, Sangeeta Maruti, Bulman, William, Kennedy, Giulia C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740045/ https://www.ncbi.nlm.nih.gov/pubmed/34991528 http://dx.doi.org/10.1186/s12890-021-01772-4 |
Ejemplares similares
-
Clinical validation and utility of Percepta GSC for the evaluation of lung cancer
por: Mazzone, Peter, et al.
Publicado: (2022) -
Analytical validation of the Percepta genomic sequencing classifier; an RNA next generation sequencing assay for the assessment of Lung Cancer risk of suspicious pulmonary nodules
por: Johnson, Marla K., et al.
Publicado: (2021) -
Molecular Profiling of Thyroid Nodules: Current Role for the Afirma Gene Expression Classifier on Clinical Decision Making
por: Kloos, Richard T.
Publicado: (2017) -
Impact of an integrated classifier using biomarkers, clinical and imaging factors on clinical decisions making for lung nodules
por: Kheir, Fayez, et al.
Publicado: (2023) -
Using Decision Trees to Support Classifiers’ Decision-Making about Activity Limitation of Cerebral Palsy Footballers
por: Sarabia, José M., et al.
Publicado: (2021)